98 related articles for article (PubMed ID: 24137971)
1. [The combined drug ascoril in the treatment of patients with chronic obstructive pulmonary disease concurrent with coronary heart disease].
Grigor'eva NIu; Kuznetsov AN; Koroleva TV; Koroleva ME
Ter Arkh; 2013; 85(8):91-4. PubMed ID: 24137971
[TBL] [Abstract][Full Text] [Related]
2. [Effect of mucolytic therapy on the production of reactive oxygen species in the blood of patients with an exacerbation of chronic obstructive pulmonary disease].
Farkhutdinov UR; Farkhutdinov RR; Petriakov VV; Farkhutdinov ShU; Mirkhaĭdarov AM
Ter Arkh; 2010; 82(3):29-32. PubMed ID: 20564918
[TBL] [Abstract][Full Text] [Related]
3. [The effect of inhaled ambroxol treatment on clinical symptoms and chosen parameters of ventilation in patients with exacerbation of chronic obstructive pulmonary disease patients].
Jahnz-Rózyk K; Kucharczyk A; Chciałowski A; Płusa T
Pol Merkur Lekarski; 2001 Sep; 11(63):239-43. PubMed ID: 11761819
[TBL] [Abstract][Full Text] [Related]
4. [Results of international multicentre non-interventional clinical study of the effectiveness and safety of ascoril expectorant for the treatment of cough in Kazakhstan and Uzbekistan].
Nurgozhin TS; Guliaev AE; Ermekbaeva BA; Zhaugasheva SK; Abuova GT; An ÉA
Klin Med (Mosk); 2013; 91(6):50-5. PubMed ID: 24417069
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathogenetic features of coronary heart disease combined with chronic obstructive pulmonary diseases and efficiency of therapy with trimetazidin].
Kolomoets NM; Baksheev VI; Uvaĭsova KU
Klin Med (Mosk); 2008; 86(6):38-43. PubMed ID: 18720710
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of mild exacerbations of chronic obstructive pulmonary disease].
Kliachkina IL; Dmitriev IuK
Klin Med (Mosk); 2012; 90(3):69-73. PubMed ID: 22690572
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of Ascoril expectorant and other cough formula in the treatment of cough management in paediatric and adult patients--a randomised double-blind comparative trial.
Jayaram S; Desai A
J Indian Med Assoc; 2000 Feb; 98(2):68-70. PubMed ID: 11016157
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic modalities for the management of cough associated with acute respiratory viral infection, effective in an otolaryngologist's practice].
Ovchinnikov AI; Paniakina MA; Korostelev SA; Mitiuk AM
Vestn Otorinolaringol; 2014; (2):86-9. PubMed ID: 24781181
[TBL] [Abstract][Full Text] [Related]
9. Heart rate-lowering efficacy and respiratory safety of ivabradine in patients with obstructive airway disease: a randomized, double-blind, placebo-controlled, crossover study.
Majewski S; Slomka S; Zielinska-Wyderkiewicz E; Ciebiada M; Gorski P
Am J Cardiovasc Drugs; 2012 Jun; 12(3):179-88. PubMed ID: 22409211
[TBL] [Abstract][Full Text] [Related]
10. [Chronic obstructive pulmonary disease exacerbation. Do we use all possibilities of outpatient therapy?].
Leshchenko IV
Ter Arkh; 2013; 85(10):83-7. PubMed ID: 24437224
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of Ascoril in the management of cough--National Study Group report.
Ainapure SS; Desai A; Korde K
J Indian Med Assoc; 2001 Feb; 99(2):111, 114. PubMed ID: 11482804
[TBL] [Abstract][Full Text] [Related]
12. [Ambroxol].
Akkoca Yildiz O
Tuberk Toraks; 2006; 54 Suppl 1():3-14. PubMed ID: 17089236
[No Abstract] [Full Text] [Related]
13. Long-term survival of patients with chronic obstructive pulmonary disease undergoing coronary artery bypass surgery.
Leavitt BJ; Ross CS; Spence B; Surgenor SD; Olmstead EM; Clough RA; Charlesworth DC; Kramer RS; O'Connor GT;
Circulation; 2006 Jul; 114(1 Suppl):I430-4. PubMed ID: 16820614
[TBL] [Abstract][Full Text] [Related]
14. Oral neltenexine in patients with obstructive airways diseases: an open, randomised, controlled comparison versus sobrerol.
Fadda G
Minerva Med; 2001 Aug; 92(4):269-75. PubMed ID: 11535970
[TBL] [Abstract][Full Text] [Related]
15. [Biochemical markers of endothelial dysfunction in chronic obstructive pulmonary disease concurrent with hypertensive disease or coronary heart disease].
Akhmineeva AKh
Ter Arkh; 2014; 86(3):20-3. PubMed ID: 24779065
[TBL] [Abstract][Full Text] [Related]
16. [Effects of oxatomide, H1-antagonist, on postinfectious chronic cough; a comparison of oxatomide combined with dextromethorphan versus dextromethorphan alone].
Fujimori K; Suzuki E; Arakawa M
Arerugi; 1998 Jan; 47(1):48-53. PubMed ID: 9528165
[TBL] [Abstract][Full Text] [Related]
17. [Antioxidative features of ambroxol--usefulness in COPD].
Nowak D
Pneumonol Alergol Pol; 2001; 69(9-10):590-3. PubMed ID: 11928667
[No Abstract] [Full Text] [Related]
18. [Heart rhythm disturbances in patients with chronic obstructive pulmonary disease in aggregate with coronary heart disease].
Shoĭkhet IaN; Klester EB; Golovin VA
Klin Med (Mosk); 2008; 86(3):21-6. PubMed ID: 18441699
[TBL] [Abstract][Full Text] [Related]
19. Effect of chronic obstructive pulmonary disease on survival of patients with coronary heart disease having percutaneous coronary intervention.
Berger JS; Sanborn TA; Sherman W; Brown DL
Am J Cardiol; 2004 Sep; 94(5):649-51. PubMed ID: 15342301
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the efficacy and safety of a combination drug containing ambroxol, guaifenesin, and levosalbutamol versus a fixed-dose combination of bromhexine/guaifenesin/salbutamol in the treatment of productive cough in adult patients with acute bronchitis].
Zaitsev AA; Leshchenko IV; Esaulova NA; Viktorova IA
Ter Arkh; 2023 Apr; 95(3):236-242. PubMed ID: 37167145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
